Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

BSH 2024

The 64th Annual Scientific Meeting of the British Society for Haematology

28–30 April 2024 | Liverpool, UK

The 64th Annual Scientific Meeting of the British Society for Haematology (BSH) took place on 28-30 April 2024 in Liverpool, UK, and brought together hematology professionals to discuss advances in the field.

View all videos

The impact of TET2 mutations on hematopoietic stem cell resilience to immune-related stress

Hector Huerga Encabo • 25 Apr 2024

Treating patients with advanced-stage HL in the frontline and relapsed settings in 2024

Graham Collins • 29 Apr 2024

Developments in the treatment of patients with FLT3-mutated AML

Steven Knapper • 1 May 2024

Frontline treatment of transplant eligible patients with myeloma: current approach & future changes

Karthik Ramasamy • 28 Apr 2024

Treating young patients with MPN

Claire Harrison • 29 Apr 2024

The current therapeutic landscape for indolent and advanced systemic mastocytosis

Deepti Radia • 29 Apr 2024

What can clinicians do to address the impact of transfusion-dependent thalassemia on patients’ QoL?

Farrukh Shah • 30 Apr 2024

Optimizing the delivery of care for patients with hemoglobinopathies in the UK

Farrukh Shah • 30 Apr 2024

The impact of TET2 mutations on hematopoietic stem cell resilience to immune-related stress

Hector Huerga Encabo • 25 Apr 2024

Developments in the treatment of patients with FLT3-mutated AML

Steven Knapper • 1 May 2024

Key papers in cardio-oncology from 2023 of relevance to hematologists

Alex Lyon • 25 Apr 2024

The ESC guidelines on cardio-oncology: incorporating the guidelines into clinical practice

Alex Lyon • 25 Apr 2024